Diabetes research investment in the European Union

Article Abstract:

The European Union has invested a large sum of money in addition to that invested by the US National Institutes of Health (NIH) to conduct research to cure diabetes, which decreases the life expectancy and the quality of life of the people affected by it. The results emphasize the immediate need for the collaboration between Europe and America to fund the diabetes researches, as urgent action is necessary for the diabetic people.

Government expenditures, Diabetes R&D, Diabetes, European Union, Diabetes research, Government finance

---

After criticism, more modest cancer genome project takes shape

Article Abstract:

The US National Institutes of Health is set to begin taking applications for the expensive federal project, The Cancer Genome Atlas, to identify the genetic changes that cause cancer in spite of loud skepticism from some scientists. Its goal is to scan the genome of tumors and catalog the genetic alterations associated with cancer that will help researchers develop cancer drugs.

Science & research, Cancer & Cell R&D, Research, Cancer research, Cancer, Genomes, Cancer genetics, Oncology, Experimental

---

List of 'prurient' research stirs fear, anger among US scientists

Article Abstract:

More than 150 National Institutes of Health (NIH)- funded scientists conducting behavioral research on HIV/AIDS transmission, homosexuality and drug-abuse is stirring anger and fear among US scientists. Ken Mayer remarks to avoid the spread of AIDS; it is essential to understand triggers and cultural influences on behavior.

Management dynamics, Research Personnel, Care and treatment, Management, HIV infection, HIV infections, Company business management, Research scientists

Similar abstracts:

• Abstracts: Researchers identify protein that helps tumor cells resist cancer drugs. Studies show tissues surrounding tumors have a role in cancer progression
• Abstracts: The rise of the HCAs. We are people who can get things done. Creating a better work environment
• Abstracts: Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.